Christopher Bot
Impact in
- Epidemiology top 10%
- Trypanosoma species research and implications
-
- PARP inhibition in cancer therapy
Papers in
-
- Trypanosoma species research and implications 7
-
- Bioactive Compounds and Antitumor Agents 1
- Co-authors
- Shane R. Wilkinson (5 shared papers)Belinda S. Hall (5 shared papers)John M. Kelly (4 shared papers)Samson O. Obado (3 shared papers)Martin Craig Taylor (3 shared papers)Daniel Nilsson (1 shared paper)Björn Andersson (1 shared paper)Annika Pfeiffer (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Scientific Reports (1 paper)Nature Communications (1 paper)Current Topics in Medicinal Chemistry (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomSwedenColombia
In The Last Decade
Christopher Bot
12 papers receiving 871 citations
Christopher Bot's Hit Papers
Peers
Comparison fields: 5 of 55
- Epidemiology 345
- Oncology 160
- Molecular Biology 257
- Toxicology 20
- Cell Biology 35
Countries citing papers authored by Christopher Bot
This map shows the geographic impact of Christopher Bot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bot more than expected).
Fields of papers citing papers by Christopher Bot
This network shows the impact of papers produced by Christopher Bot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bot. The network helps show where Christopher Bot may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Bot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance Hit paper breakdown → | 2021 | 286 |
| 2 | 2011 | 211 | |
| 3 | 2011 | 113 | |
| 4 | 2007 | 60 | |
| 5 | 2017 | 46 | |
| 6 | 2010 | 44 | |
| 7 | 2011 | 37 | |
| 8 | 2013 | 35 | |
| 9 | 2010 | 21 | |
| 10 | 2012 | 21 | |
| 11 | 2020 | 6 | |
| 12 | 2017 | 3 |
About Christopher Bot
Christopher Bot is a scholar working on Epidemiology, Toxicology, Cell Biology, Plant Science and Immunology, having authored 12 papers that have together received 883 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (7 papers), Chromosomal and Genetic Variations (2 papers), DNA Repair Mechanisms (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Synthesis and biological activity (1 paper), Cancer therapeutics and mechanisms (1 paper), Microtubule and mitosis dynamics (1 paper) and Organophosphorus compounds synthesis (1 paper). The work is most often cited by research in Epidemiology (345 citations), Oncology (160 citations), Molecular Biology (257 citations), Toxicology (20 citations) and Cell Biology (35 citations). Christopher Bot has collaborated with scholars based in United Kingdom, Sweden and Colombia. Frequent co-authors include Shane R. Wilkinson, Belinda S. Hall, John M. Kelly, Samson O. Obado, Martin Craig Taylor, Daniel Nilsson, Björn Andersson, Annika Pfeiffer, Lena Ström and Nico P. Dantuma. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Scientific Reports, Nature Communications, Current Topics in Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.